I initiate coverage on Forte Biosciences stock at a 'Hold' rating due to both pipeline risk and upcoming clinical catalysts.

The separation in 2026 will not be between companies that “use AI” and those that do not. It will be between companies that ...

Dubai, the most populous of the United Arab Emirates, is the destination of choice for south Asians and westerners hungry for ...

In early 2024, the Islamic Republic of Iran was riding high. It was the dominant external actor in four Middle Eastern states: Iraq, Lebanon, Syria, and Yemen. Its missiles and armed proxies menaced ...

ProQR Therapeutics is a high-potential, early-stage RNA editing platform company, but remains pre-proof-of-mechanism in ...

Something extraordinary is happening in American science right now. Even amid budget debates, political headwinds, and ...

While companies continue to invest heavily in digital infrastructure, many lack the skills needed to translate data into ...

Soaring energy costs led to the biggest monthly increase in the Consumer Price Index since the peak of the post-pandemic ...

Here’s something no American wants to hear: Prices are surging again, and uncomfortably high inflation could be with us for ...

By Howard Schneider WASHINGTON, April 10 (Reuters) - When surging U.S. inflation peaked in June of 2022, driven by rising ...

WASHINGTON (AP) — The largest monthly jump in gas prices in six decades caused a sharp spike in inflation in March, creating ...

In our news wrap Friday, the latest inflation report shows the biggest price increase since 2024, the Trump administration ...